1. Clinical Overview
Methylcobalamin is the active, coenzyme form of Vitamin B12 (Cobalamin). It is a crucial cofactor for two vital enzymatic reactions in humans: methionine synthase (involved in homocysteine metabolism and DNA synthesis) and L-methylmalonyl-CoA mutase (involved in fatty acid and amino acid metabolism). Unlike cyanocobalamin, it is directly bioavailable and does not require hepatic conversion, making it the preferred form for neurological support and in patients with compromised liver or kidney function. In the Indian context, it is widely prescribed for neuropathic pain, diabetic neuropathy, and B12 deficiency syndromes.
| Onset | Duration | Bioavailability |
|---|---|---|
| Hematological response (reticulocyte count increase) can begin within 3-5 days. Subjective neurological symptom improvement (e.g., paresthesia) may take 1-2 weeks. Full hematological correction typically takes 4-8 weeks. | The duration is dose and storage-dependent. Following a single 500mcg intramuscular dose, serum levels remain elevated for several days to weeks. With oral supplementation, daily dosing is recommended due to its water-soluble nature and renal excretion. | Oral bioavailability is low (~1-3%) via passive diffusion, but can increase to ~5-10% with high doses (500-1000mcg) due to mass action. Intramuscular/Subcutaneous administration has nearly 100% bioavailability. |
2. Mechanism of Action
Methylcobalamin acts as a coenzyme for two key metabolic pathways: 1) In the cytoplasm, it is a cofactor for methionine synthase, which catalyzes the conversion of homocysteine to methionine. Methionine is then converted to S-adenosylmethionine (SAMe), a universal methyl donor crucial for DNA/RNA synthesis, neurotransmitter production, and myelin maintenance. 2) In mitochondria, its isomer adenosylcobalamin (to which it can be converted) is a cofactor for L-methylmalonyl-CoA mutase, which converts methylmalonyl-CoA to succinyl-CoA, a critical step in the metabolism of odd-chain fatty acids and certain amino acids (valine, isoleucine).
3. Indications & Uses
- Vitamin B12 deficiency (Megaloblastic anemia, Neurological manifestations like peripheral neuropathy, subacute combined degeneration of spinal cord)
- Diabetic Peripheral Neuropathy (symptomatic relief of pain, paresthesia)
- Nutritional supplementation in vegetarians/vegans, elderly with atrophic gastritis
4. Dosage & Administration
Adult Dosage: Deficiency Treatment: 500mcg to 1500mcg daily orally, or 500mcg intramuscularly (IM) daily for 5-7 days, then 500mcg IM weekly for 4 weeks, then monthly. Maintenance: 500mcg to 1500mcg daily orally or 500mcg IM monthly. Diabetic Neuropathy: 500mcg to 1500mcg daily orally or 500mcg IM 3 times a week for 4-8 weeks, then maintenance.
Administration: Oral: Take with or without food. Sublingual tablets: Allow to dissolve under the tongue. Injection: For IM or deep subcutaneous use only. Must be administered by a healthcare professional. Avoid intravenous administration. Protect injection vials from light.
5. Side Effects
Common side effects may include:
- Mild diarrhea
- Itching
- Skin rash
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Chloramphenicol | May decrease the hematological response to Methylcobalamin. | Moderate |
| Proton Pump Inhibitors (Omeprazole, Pantoprazole) | Long-term use reduces gastric acid, impairing protein-bound B12 release from food, but not high-dose Methylcobalamin absorption. | Low |
| H2 Receptor Antagonists (Ranitidine, Famotidine) | Similar to PPIs, may reduce dietary B12 absorption. | Low |
| Metformin | Chronic use can reduce B12 absorption by interfering with calcium-dependent IF-B12 complex formation in ileum. Increases requirement for Methylcobalamin. | Moderate |
| Colchicine | May impair B12 absorption by affecting ileal mucosa. | Moderate |
| Aminoglycosides, Colistin | May reduce intestinal absorption of B12. | Moderate |
| Antiepileptics (Phenytoin, Phenobarbital) | May reduce serum B12 levels, mechanism unclear. | Moderate |
| Folic Acid | High-dose folic acid without B12 can correct anemia but mask/worsen neurological degeneration. | High |
7. Patient Counselling
- Do take the medication regularly as prescribed.
- Do inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- Do get regular blood tests (CBC, B12 levels) as advised to monitor response.
- Don't stop medication abruptly if taking for a deficiency; complete the full course.
- Don't rely solely on supplements if dietary cause is correctable; discuss diet with doctor/nutritionist.
8. Toxicology & Storage
Overdose: Extremely low toxicity even at very high doses. No specific syndrome of acute overdose. Symptoms would be related to side effects (diarrhea, itching, rash).
Storage: Store below 30°C. Protect from light and moisture. Keep out of reach of children. For injections: Do not freeze. Use immediately after opening ampoule/vial. Discard any unused portion.